Profilo
Graham Watman was Executive Chairman of Grant
Thornton (Sydney) and is a non-executive Director
of a number of companies.
Precedenti posizioni note di Allan Graham Watman
| Società | Posizione | Fine |
|---|---|---|
| MANALTO LIMITED | Fondatore | 17/12/2007 |
Cryptome Pharmaceuticals Ltd.
 Cryptome Pharmaceuticals Ltd. BiotechnologyHealth Technology Cryptome Pharmaceuticals Ltd is a globally-linked, Melbourne-based biotechnology company created to discover and develop effective and safe protein-derived medicines targeting cancer, cardiovascular disease and chronic inflammatory disorders using a proprietary proteomics-based technology platform. | Direttore/Membro del Consiglio | 05/04/2006 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Cryptome Pharmaceuticals Ltd.
Cryptome Pharmaceuticals Ltd. BiotechnologyHealth Technology Cryptome Pharmaceuticals Ltd is a globally-linked, Melbourne-based biotechnology company created to discover and develop effective and safe protein-derived medicines targeting cancer, cardiovascular disease and chronic inflammatory disorders using a proprietary proteomics-based technology platform. | Health Technology |
Manalto Ltd.
 Manalto Ltd. Packaged SoftwareTechnology Services Manalto Ltd. engages in the development and commercialization of social media management software. It operates through the following geographical segments: Australia, USA, Ireland, South Africa, and the Netherlands. The company was founded by Gregory Edward Rice, Nick Gatsios, Anthony Owen and Allan Graham Watman on November 2, 2001 and is headquartered in Annangrove, Australia. | Technology Services |
- Borsa valori
- Insiders
- Allan Graham Watman
